Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study

The European Journal of Neuroscience
Corinde E WiersN D Volkow

Abstract

Dopamine transporters (DAT) are implicated in the pathogenesis and treatment of attention-deficit hyperactivity disorder (ADHD) and are upregulated by chronic treatment with methylphenidate, commonly prescribed for ADHD. Methylation of the DAT1 gene in brain and blood has been associated with DAT expression in rodents' brains. Here we tested the association between methylation of the DAT1 promoter derived from blood and DAT availability in the striatum of unmedicated ADHD adult participants and in that of healthy age-matched controls (HC) using Positron Emission Tomography (PET) and [11 C]cocaine. Results showed no between-group differences in DAT1 promoter methylation or striatal DAT availability. However, the degree of methylation in the promoter region of DAT1 correlated negatively with DAT availability in caudate in ADHD participants only. DAT availability in VS correlated with inattention scores in ADHD participants. We verified in a postmortem cohort with ADHD diagnosis and without, that DAT1 promoter methylation in peripheral blood correlated positively with DAT1 promoter methylation extracted from substantia nigra (SN) in both groups. In the cohort without ADHD diagnosis, DAT1 gene expression in SN further correlated po...Continue Reading

References

Feb 1, 1993·Trends in Pharmacological Sciences·B Giros, M G Caron
Sep 1, 1996·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J LoganD L Alexoff
Feb 2, 2000·Neuroscience and Biobehavioral Reviews·J M SwansonM Posner
Apr 11, 2003·Journal of Attention Disorders·N D VolkowS J Gatley
Aug 6, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·K LangleyA Thapar
May 23, 2007·Clinical Nuclear Medicine·Andrew NewbergP David Mozley
Apr 18, 2008·Expert Review of Neurotherapeutics·Johanna Krause
Mar 19, 2009·JAMA : the Journal of the American Medical Association·Nora D VolkowKaren Apelskog-Torres
Sep 10, 2009·JAMA : the Journal of the American Medical Association·Nora D VolkowJames M Swanson
Jan 27, 2011·PloS One·Fabienne BrenetJoseph M Scandura
Apr 12, 2011·Current Pharmaceutical Design·Yu-Shu HuangChristian Guilleminault
May 6, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gianluca UrsiniAlessandro Bertolino
Aug 10, 2011·PloS One·Elena ShumayNora D Volkow
Sep 29, 2011·European Archives of Psychiatry and Clinical Neuroscience·Corinde E Wiers
Feb 2, 2012·The American Journal of Psychiatry·Paolo Fusar-PoliUmberto Balottin
May 30, 2012·Nature Reviews. Genetics·Peter A Jones
Sep 6, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Elena ShumayJoanna S Fowler
Jul 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·Mark J FerrisSara R Jones
Aug 5, 2014·Nature Neuroscience·Yuliya S NikolovaAhmad R Hariri
Aug 15, 2014·Journal of Neurophysiology·Abigail Z RajalaLuis C Populin
Jun 9, 2015·Trends in Cognitive Sciences·Yuliya S Nikolova, Ahmad R Hariri
Sep 28, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Kaijing DingChuanyuan Kang
Mar 12, 2017·Biological Psychiatry·Ryan BogdanDavid Goldman
Aug 13, 2017·Neuroscience·Katie LancasterJessica J Connelly

❮ Previous
Next ❯

Citations

May 15, 2019·Current Opinion in Neurology·Sabine Hellwig, Katharina Domschke
Mar 30, 2020·MMW Fortschritte der Medizin·Kristina Adorjan, Oliver Pogarell
Jun 27, 2020·Brain Sciences·Anna GrzywaczBlazej Rubiś
Nov 3, 2020·Neuropharmacology·Annika L WeißMarieke Klein
Jun 26, 2021·Journal of Psychiatric Research·Zeinab Shirvani-FarsaniIman Sadeghi
Oct 16, 2021·Molecular Psychiatry·Maarten E A ReithZhicheng Lin
Aug 19, 2021·AJR. American Journal of Roentgenology·Fatemeh Dehghani FirouzabadiDavid M Yousem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.